Assignee
SILVERGATE PHARMACEUTICALS INC
US·25 granted patents·2 pending applications·216 citations·filing 2013–2021
Top patents by PatentIndex Score
27 records- 0198US11771733B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Oct 3, 2023·4 cites·20 claims
- 0298US11179434B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Nov 23, 2021·7 cites·18 claims
- 0398US10940177B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 9, 2021·8 cites·19 claims
- 0498US10265370B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·10 cites·20 claims
- 0598US10039800B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Aug 7, 2018·12 cites·20 claims
- 0698US9814751B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2017·13 cites·20 claims
- 0798US9616096B1Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2016·Granted Apr 11, 2017·23 cites·20 claims
- 0898US9463183B1Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·35 cites·13 claims
- 0997US10959991B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 30, 2021·4 cites·20 claims
- 1097US10952998B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 23, 2021·6 cites·30 claims
- 1197US10894039B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·8 cites·19 claims
- 1297US10695329B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Jun 30, 2020·14 cites·14 claims
- 1397US10406199B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Sep 10, 2019·8 cites·20 claims
- 1497US9808442B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Nov 7, 2017·8 cites·30 claims
- 1597US9669008B1Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2016·Granted Jun 6, 2017·13 cites·20 claims
- 1696US10918621B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·30 claims
- 1796US10799476B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Oct 13, 2020·3 cites·14 claims
- 1895US11040023B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Jun 22, 2021·2 cites·20 claims
- 1995US10799453B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·7 cites·19 claims
- 2094US10772868B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·3 cites·30 claims
- 2194US10039745B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Aug 7, 2018·4 cites·20 claims
- 2293US10154987B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Dec 18, 2018·3 cites·30 claims
- 2390US9855214B2Enalapril compositionsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Jan 2, 2018·9 cites·17 claims
- 2489US10786482B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Sep 29, 2020·1 cites·28 claims
- 2589US9968553B1Enalapril compositionsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·8 cites·30 claims
- 2673US2020206298A1Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2759US2015258027A1Enalapril compositionsSILVERGATE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SILVERGATE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →